Murakami Yoshiko, Kinoshita Taroh
Nihon Rinsho. 2015 Jul;73(7):1227-37.
Recently, many cases of inherited GPI deficiency(IGD) are found among individuals with intellectual disability and intractable seizures. To date, about twenty patients have been reported in Japan and up to a hundred in the world. GPI is the glycolipid which anchors 150 kinds of proteins to the plasma membrane. We have found that there are at least 26 genes involved in the biosynthesis or modification of GPI-anchored proteins. IGDs caused by mutations in 12 genes were reported until now. IGD shows a variety of symptoms according to the affected genes and the severity of the mutations. Some patients have hyperphosphatasia and most patients can be diagnosed by the flow cytometric analysis of the blood cells. Early diagnosis and treatment are desirable because the disease progresses even after birth and vitamin B6(pyridoxine) is very effective for some patients with intractable seizures.
最近,在智障和难治性癫痫患者中发现了许多遗传性糖基磷脂酰肌醇缺乏症(IGD)病例。迄今为止,日本已报告约20例患者,全球多达100例。糖基磷脂酰肌醇是一种糖脂,可将150种蛋白质锚定在质膜上。我们发现至少有26个基因参与糖基磷脂酰肌醇锚定蛋白的生物合成或修饰。到目前为止,已报告了由12个基因突变引起的IGD。根据受影响的基因和突变的严重程度,IGD表现出多种症状。一些患者有高磷酸酶血症,大多数患者可通过血细胞的流式细胞术分析进行诊断。由于该疾病即使在出生后仍会进展,且维生素B6(吡哆醇)对一些难治性癫痫患者非常有效,因此早期诊断和治疗是可取的。